Skip to main content
    I

    Iradimed Co (IRMD)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $89.37
    -0.46 (-0.51%)

    Market Cap: $1.15B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    87%(34/39)
    Avg Surprise
    +39.23%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.55
    Range$0.54 - $0.56
    3 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.54+1.9%
    60d ago$0.54+1.9%
    30d ago$0.55+0.9%
    7d ago$0.55+0.9%
    Current$0.55
    Revenue Consensus
    $23M
    Range$23M - $24M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.68
    Range$0.66 - $0.72
    3 analysts
    Revenue Consensus
    $27M
    Range$26M - $29M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.68---
    Sep 26EST
    		-$0.55---
    Jun 26
    Reported Jul 31
    		$0.41$0.42-2.38%Miss-16.3%
    Mar 26
    Reported May 1
    		$0.49$0.45+8.89%Beat+16.7%
    Dec 25
    Reported Feb 10
    		$0.54$0.48+12.50%Beat+35.0%
    Sep 25
    Reported Nov 3
    		$0.47$0.46+2.17%Beat+9.3%
    Jun 25
    Reported Aug 1
    		$0.49$0.44+11.36%Beat+16.7%
    Mar 25
    Reported May 5
    		$0.42$0.41+2.44%Beat+16.7%
    Dec 24
    Reported Feb 13
    		$0.40$0.41-2.44%Miss+2.6%
    Sep 24
    Reported Oct 31
    		$0.43$0.39+10.26%Beat+0.0%
    Jun 24
    Reported Aug 1
    		$0.42$0.37+13.51%Beat+16.7%
    Mar 24
    Reported May 2
    		$0.36$0.34+5.88%Beat+20.0%
    Dec 23
    Reported Feb 8
    		$0.39$0.38+2.63%Beat+21.9%
    Sep 23
    Reported Nov 3
    		$0.43$0.37+16.22%Beat+48.3%
    Jun 23
    Reported Aug 3
    		$0.36$0.31+16.13%Beat+38.5%
    Mar 23
    Reported May 4
    		$0.30$0.27+11.11%Beat+36.4%
    Dec 22
    Reported Feb 2
    		$0.32$0.31+3.23%Beat-3.0%
    Sep 22
    Reported Nov 3
    		$0.29$0.24+20.83%Beat+26.1%
    Jun 22
    Reported Jul 29
    		$0.26$0.24+8.33%Beat+85.7%
    Mar 22
    Reported Apr 29
    		$0.22$0.21+4.76%Beat+69.2%
    Dec 21
    Reported Feb 4
    		$0.33$0.21+57.14%Beat+371.4%
    Sep 21
    Reported Oct 29
    		$0.23$0.17+35.29%Beat+109.1%
    Jun 21
    Reported Jul 30
    		$0.14$0.15-6.67%Miss+180.0%
    Mar 21
    Reported Apr 30
    		$0.13$0.09+44.44%Beat-27.8%
    Dec 20
    Reported Feb 4
    		$0.07$0.09-22.22%Miss-76.7%
    Sep 20
    Reported Oct 30
    		$0.11$0.05+120.00%Beat-52.2%
    Jun 20
    Reported Jul 30
    		$0.05$-0.04+225.00%Beat-75.0%
    Mar 20
    Reported Apr 30
    		$0.18$0.12+50.00%Beat+38.5%
    Dec 19
    Reported Feb 6
    		$0.30$0.20+50.00%Beat+87.5%
    Sep 19
    Reported Oct 30
    		$0.23$0.15+53.33%Beat+64.3%
    Jun 19
    Reported Jul 30
    		$0.20$0.15+33.33%Beat+42.9%
    Mar 19
    Reported Apr 30
    		$0.13$0.13+0.00%Beat+30.0%
    Dec 18
    Reported Feb 6
    		$0.16$0.13+23.08%Beat+60.0%
    Sep 18
    Reported Oct 30
    		$0.14$0.10+40.00%Beat+100.0%
    Jun 18
    Reported Jul 31
    		$0.14$0.10+40.00%Beat+133.3%
    Mar 18
    Reported Apr 30
    		$0.10$0.06+66.67%Beat+600.0%
    Dec 17
    Reported Feb 6
    		$0.10$0.06+66.67%Beat-9.1%
    Sep 17
    Reported Oct 30
    		$0.07$0.03+133.33%Beat-
    Jun 17
    Reported Jul 28
    		$0.06$0.01+500.00%Beat-
    Mar 17
    Reported Apr 28
    		$-0.02$0.01-300.00%Miss-
    Dec 16
    Reported Feb 6
    		$0.11$0.04+175.00%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.90%
    Forward Annual Dividend$0.80
    Payout Ratio42.70%
    FrequencyQuarterly
    Pay MonthsMar, May, Aug, Nov, Dec
    IRMD dividend history and ex-dividend datesRun IRMD in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio46.79EV/EBITDA34.53x
    Price/FCF45.94xFCF Yield2.18%
    Profitability
    Profit Margin26.70%Operating Margin31.20%
    ROE23.50%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio9.46xQuick Ratio8.13x
    Trading Statistics
    Beta0.91Avg Volume129.60K
    52-Week High$107.2052-Week Low$72.02

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$87.38
    SMA 20$86.34
    SMA 50$86.31
    SMA 200$93.01
    EMA 10$87.92
    EMA 20$86.92
    EMA 50$87.29
    EMA 200$88.12

    MACD

    Line: 0.87Signal: 0.28Hist: 0.59

    ADX

    ADX: 20.5+DI: 22.9-DI: 11.4

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$85.39

    Bollinger Bands

    Upper Band$90.53
    Lower Band$82.16
    %B Position970%(Upper)
    Band Width0.86

    RSI (14-Day)

    Neutral
    62.6

    Momentum Oscillators

    Stoch %K85.0
    Stoch %D89.6
    Williams %R-23.3
    ROC (10d)4.8%
    Momentum4.07
    CCI (20d)168.0
    MFI (14d)47.7

    Volatility Measures

    ATR (14d)$2.17(2.4%)
    StdDev (20d)2.09
    Hist Vol23.4%(Moderate)

    Volume Flow

    VWAP$89.85
    OBV2.3M
    AD Line-13.5M
    CMF (20d)0.025

    Volume Metrics

    Avg Vol (20d)132.2K
    Vol Ratio0.6x
    VWMA (20d)$85.99

    Pivot Points

    R3$91.42
    R2$90.92
    R1$90.38
    Pivot Point$89.88
    S1$89.34
    S2$88.84
    S3$88.30

    Advanced Oscillators

    TSI14.74
    Ultimate Osc59.3
    KST26.03

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$20.47M$21.98M$22.69M$21.20M$20.41M$19.51M$19.39M$18.33M$17.93M$17.60M$17.45M$16.50M
    Cost of Revenue$5.31M$5.17M$5.66M$4.71M$4.45M$4.67M$4.63M$4.13M$3.92M$4.21M$4.04M$3.67M
    Gross Profit$15.16M$16.81M$17.03M$16.49M$15.96M$14.84M$14.76M$14.19M$14.01M$13.39M$13.41M$12.84M
    Operating Expenses$8.77M$9.58M$9.94M$9.66M$9.17M$9.41M$8.96M$8.40M$8.38M$8.64M$8.25M$6.93M
    R&D$657,000$956,000$799,031$674,362$877,000$624,000$570,404$639,467$801,129$821,000$-1,555,827$452,555
    SG&A$3.87M$4.57M$4.54M$4.36M$4.28M$4.61M$3.87M$3.97M$4.10M$3.99M$4.27M$3.62M
    Operating Income$6.39M$7.24M$7.09M$6.83M$6.79M$5.43M$5.80M$5.79M$5.63M$4.75M$5.16M$5.91M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$6.89M$7.77M$7.79M$7.30M$7.33M$5.95M$6.34M$6.42M$6.27M$5.24M$5.68M$6.41M
    Income Tax Expense$1.67M$1.95M$1.35M$1.72M$1.55M$1.26M$1.20M$1.37M$1.37M$1.11M$1.14M$1.34M
    Net Income$5.22M$5.82M$6.44M$5.58M$5.77M$4.69M$5.15M$5.05M$4.90M$4.14M$4.54M$5.07M
    EBITDA$7.30M$8.22M$8.17M$7.68M$7.54M$6.14M$6.54M$6.62M$6.47M$5.47M$5.89M$6.60M
    EBIT$6.89M$7.77M$7.79M$7.30M$7.33M$5.95M$6.34M$6.42M$6.27M$5.24M$5.68M$6.41M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IRMD

    Government Contracts

    Gov Obligations (TTM)
    $770321
    Gov Obligations / Revenue
    0.9%
    Obligations YoY
    N/A
    Active Awards
    13
    New Awards (TTM)
    10
    Avg Remaining Term
    6.2 mo

    Top agency: Department of Veterans Affairs at 88.7% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24726P0713Department of Veterans AffairsDepartment of Veterans Affairs$211437Jul 29, 2026
    36C24726P0379Department of Veterans AffairsDepartment of Veterans Affairs$110056Mar 10, 2026
    36C25726P0382Department of Veterans AffairsDepartment of Veterans Affairs$102246Apr 1, 2026
    36C24725P1035Department of Veterans AffairsDepartment of Veterans Affairs$83872Aug 13, 2025
    36C24626P0866Department of Veterans AffairsDepartment of Veterans Affairs$74105Jul 22, 2026
    75N98026P00918Department of Health and Human ServicesNational Institutes of Health$70866Jun 30, 2026
    36C24726P0354Department of Veterans AffairsDepartment of Veterans Affairs$57000Mar 9, 2026
    36C25726P0682Department of Veterans AffairsDepartment of Veterans Affairs$28440Jul 30, 2026
    36C24726P0732Department of Veterans AffairsDepartment of Veterans Affairs$18000Jul 27, 2026
    HT941026PE029Department of DefenseDefense Health Agency$16140Feb 2, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    IRMD Form 4 Filings - iRadimed Corporation SEC Form 4

    This article provides a comprehensive list of iRadimed Corporation (IRMD) Form 4 SEC filings over the last 12 months, detailing insider transactions such as stock unit conversions, sales by directors and the CEO...

    Stock Titan•9/26/26•Somewhat-Bearish

    Form 4 Iradimed Co For: 25 September By Investing.com

    This article is a brief financial news item from Investing.com, stating that a Form 4 filing for Iradimed Co was released on September 25. The content largely consists of navigation links, popular searches...

    Investing.com Canada•9/26/26•Somewhat-Bearish

    IRadimed Director Joe Kiani Acquires 698 Shares Through RSU Vesting on September 23, 2026

    IRadimed Director Joe Kiani acquired 698 shares of common stock on September 23, 2026, through the vesting of restricted stock units. This transaction, detailed in a Statement of Changes in Beneficial Ownership...

    Kalkine Media•9/25/26•Somewhat-Bullish

    698 stock units became shares for IRADIMED (NASDAQ: IRMD) director Joe E. Kiani.

    IRADIMED CORP director Joe E. Kiani converted 698 restricted stock units into 698 common shares on September 23, 2026. Following this transaction...

    Stock Titan•9/25/26•Neutral

    One-on-one investor meetings with Iradimed's CFO are set for New York

    IRADIMED CORPORATION (NASDAQ: IRMD) announced that its CFO, Jack Glenn, will host one-on-one meetings with investors at the 5th Annual ROTH Healthcare Opportunities Conference in New York on September 29...

    Stock Titan•9/23/26•Neutral

    IRMD Valuation and Fair Value

    P/E
    46.8x
    Forward P/E
    41.1x
    EV/EBITDA
    34.5x
    P/FCF
    45.9x
    PEG
    4.5x
    P/B
    11.2x
    See GNG's fair value

    IRMD Profitability: Margins, ROIC and FCF

    Gross margin
    75.9%
    Operating margin
    31.2%
    Net margin
    26.7%
    ROE
    23.5%
    FCF margin
    28.8%
    FCF yield
    2.2%

    IRMD Competitors

    CompanyTicker
    Goodrx Holdings IncGDRX
    Taysha Gene Therapies IncTSHA
    Cronos Group IncCRON
    Vor Biopharma IncVOR
    CareCloud, Inc.CCLDO
    Omada Health, Inc. Common StockOMDA
    Oric Pharmaceuticals IncORIC
    Tandem Diabetes Care IncTNDM

    Sector: Healthcare

    IRMD Bull Case vs Bear Case

    Bull case

    • IRMD converts 28.8% of revenue into free cash flow.
    • IRMD has a 26.7% net profit margin.
    • IRMD beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • IRMD trades at 46.8x trailing earnings.

    IRMD Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    5.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.55
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    IRMD Dividend

    Forward yield
    0.9%
    Payout ratio
    42.7%
    Pay months
    Mar, May, Aug, Nov, Dec
    IRMD dividend history

    Frequently Asked Questions About IRMD

    What is IRMD's current dividend yield?

    Iradimed Co (IRMD) has a forward dividend yield of 0.90%.

    Does IRMD pay dividends?

    Yes, Iradimed Co pays dividends with a forward dividend yield of 0.90%.

    What is IRMD's P/E ratio?

    Iradimed Co has a price-to-earnings (P/E) ratio of 46.79.

    What is IRMD's market cap?

    Iradimed Co (IRMD) has a market capitalization of $1.15B with a current stock price of $89.37.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In